肺微生物组与代谢物联合关联轻度COPD临床结局
研究分析137例GOLD 0-2期COPD患者支气管肺泡灌洗液的配对微生物组与代谢组数据,采用整合方法建模14项临床变量。多数临床指标与肺微生物组和代谢组联合关联,分类准确率>50%且P<0.05。肺功能较低、COPD诊断和症状较重与链球菌属、奈瑟菌属、韦荣球菌属及糖鞘脂、甘油磷脂、多胺和黄嘌呤等化合物正相关。
要点
- 肺微生物组与代谢组联合可区分轻度COPD多项临床指标,分类准确率>50%。
- 链球菌属、奈瑟菌属、韦荣球菌属及特定脂质与较差肺功能、症状相关。
- 普雷沃菌属某些成员及腺苷等代谢物与较好肺功能、无症状相关。
核心结论
- 肺微生物组与代谢组联合成分与轻度COPD结局指标相关,提示其在疾病发病机制中的潜在协同作用。
研究设计与样本
- 研究分析SPIROMICS研究中137例GOLD 0-2期COPD参与者的支气管肺泡灌洗液配对微生物组与代谢组数据。
- 数据集包括细菌16S rRNA基因测序、疏水组分非靶向代谢组学和 hydrophilic化合物靶向代谢组学。
主要发现
- 多数临床指标与肺微生物组和代谢组联合关联,分类准确率>50%,P<0.05 vs. chance。
- 较低肺功能、COPD诊断和更重症状与链球菌属、奈瑟菌属、韦荣球菌属及糖鞘脂、甘油磷脂、多胺和黄嘌呤等化合物正相关。
- 若干普雷沃菌属成员及腺苷、5'-甲硫腺苷、唾液酸、酪氨酸和谷胱甘肽与较好肺功能、无COPD或更少症状相关。
- 特定代谢物与细菌间观察到显著相关性(Padj<0.05)。
关键数值与推荐
- 分类准确率>50%,P<0.05 vs. chance。
- 代谢物与细菌相关性Padj<0.05。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Chronic obstructive pulmonary disease (COPD) is variable in its development. Lung microbiota and metabolites collectively may impact COPD pathophysiology, but relationships to clinical outcomes in milder disease are unclear. Objectives: Identify components of the lung microbiome and metabolome collectively associated with clinical markers in milder stage COPD. Methods: We analyzed paired microbiome and metabolomic data previously characterized from bronchoalveolar lavage fluid in 137 participants in the SPIROMICS (Subpopulations and Intermediate Outcome Measures in COPD Study), or (GOLD [Global Initiative for Chronic Obstructive Lung Disease Stage 0-2). Datasets used included 1) bacterial 16S rRNA gene sequencing; 2) untargeted metabolomics of the hydrophobic fraction, largely comprising lipids; and 3) targeted metabolomics for a panel of hydrophilic compounds previously implicated in mucoinflammation. We applied an integrative approach to select features and model 14 individual clinical variables representative of known associations with COPD trajectory (lung function, symptoms, and exacerbations). Measurements and Main Results: The majority of clinical measures associated with the lung microbiome and metabolome collectively in overall models (classification accuracies, >50%, P < 0.05 vs. chance). Lower lung function, COPD diagnosis, and greater symptoms associated positively with Streptococcus, Neisseria, and Veillonella, together with compounds from several classes (glycosphingolipids, glycerophospholipids, polyamines and xanthine, an adenosine metabolite). In contrast, several Prevotella members, together with adenosine, 5'-methylthioadenosine, sialic acid, tyrosine, and glutathione, associated with better lung function, absence of COPD, or less symptoms. Significant correlations were observed between specific metabolites and bacteria (Padj < 0.05). Conclusions: Components of the lung microbiome and metabolome in combination relate to outcome measures in milder COPD, highlighting their potential collaborative roles in disease pathogenesis.
引用
- Madapoosi SS, Cruickshank-Quinn C, Opron K, et al. Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2022. PMID: 35536732. doi:10.1164/rccm.202110-2241OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。